ResMed Q4 2024 Adj. EPS $2.08 Beats $2.07 Estimate, Sales $1.232B Beat $1.217B Estimate
Author: Benzinga Newsdesk | August 01, 2024 04:07pm
ResMed (NYSE:
RMD) reported quarterly earnings of $2.08 per share which beat the analyst consensus estimate of $2.07 by 0.48 percent. The company reported quarterly sales of $1.232 billion which beat the analyst consensus estimate of $1.217 billion by 1.26 percent. This is a 9.80 percent increase over sales of $1.122 billion the same period last year.
Posted In: RMD